Skip to main content
Clinical Trials/NCT03118154
NCT03118154
Terminated
Not Applicable

Efficacy of Manual Therapy to Improve Quality of Life and Decrease Pain in Subjects With Endometriosis

Clear Passage Therapies, Inc1 site in 1 country8 target enrollmentMarch 31, 2017

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Endometriosis
Sponsor
Clear Passage Therapies, Inc
Enrollment
8
Locations
1
Primary Endpoint
Reported overall pain rating
Status
Terminated
Last Updated
8 years ago

Overview

Brief Summary

This study will compare subjects with a history of pelvic or menstrual pain diagnosed with endometriosis treated at Clear Passage with untreated control subjects. The treatment group will be a retrospective chart review; the control subject group will be a prospective questionnaire based study.

The study will assess the changes in pain experienced by subjects treated with manual therapy at Clear Passage to untreated subjects with endometriosis.

Detailed Description

This study has two segments the first is a chart and outcome assessment of patients treated at Clear Passage (CP) with a diagnosis of endometriosis. These patients have completed multiple questionnaires as a standard of care for outcome monitoring in the clinic setting, no new data will be collected. The second segment is a prospective observational, online questionnaire based study of female subjects with a diagnosis of endometriosis not treated at CP. Data on the impact of quality of life (QOL) over time of subjects not treated at CP will be assessed using the same questionnaire used as standard of care in the clinic twice, 30 days apart. This will be accomplished using online forms with subjects able to complete the questionnaires with ease via the internet. The data obtained from the untreated subjects will allow for reporting of overall impact on QOL in this population, as well as provide a control group for assessment of improvement for manual therapy interventions for patients with endometriosis.

Registry
clinicaltrials.gov
Start Date
March 31, 2017
End Date
March 31, 2018
Last Updated
8 years ago
Study Type
Observational
Sex
Female

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Diagnosis of endometriosis
  • Experience either pain with menstruation or other pelvic pain
  • Able to complete the questionnaires online

Exclusion Criteria

  • Currently pregnant
  • Cancer diagnosis
  • Prior chemotherapy or radiation treatment(s)
  • Prior treatment at Clear Passage

Outcomes

Primary Outcomes

Reported overall pain rating

Time Frame: 30 days

Self reported values using the Pain Questionnaire

Reported Pain Intensity

Time Frame: 30 days

Self reported values using the Pain Interference Questionnaire

Reported Global Health

Time Frame: 30 days

Self reported values using the Global Health Questionnaire

Reported Sexual Function

Time Frame: 30 days

Self reported values using the Female Sexual Function Index Questionnaire

Secondary Outcomes

  • Correlations to positive treatment outcomes(30 days)

Study Sites (1)

Loading locations...

Similar Trials